From a marine-derived streptomycete, a new bioactive angucyclinone, fujianmycin C (1), has been isolated along with five known, metabolites fujianmycins A (2) and B (3), ochromycinone (4), ochromycinone methyl ether (5), and tetrangulol methyl ether (6). The structure elucidation of fujianmycin C (1) was performed by detailed analysis of data such as 1H, 13C, 1H, 1H COSY, HSQC, HMBC and NOESY spectra. Fujianmycin C (1) exhibited antibacterial activity against Streptomyces viridochromogenes (Tü57).
No takes yet. Share an insight, caveat, or question.
Abdalla et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: